These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7753966)

  • 1. The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects.
    Driver HS; Flanigan MJ; Bentley AJ; Luus HG; Shapiro CM; Mitchell D
    Psychopharmacology (Berl); 1995 Jan; 117(2):186-92. PubMed ID: 7753966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls.
    Gillin JC; Sohn JW; Stahl SM; Lardon M; Kelsoe J; Rapaport M; Ruiz C; Golshan S
    Neuropsychopharmacology; 1996 Aug; 15(2):109-15. PubMed ID: 8840346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers.
    Gillin JC; Jernajczyk W; Valladares-Neto DC; Golshan S; Lardon M; Stahl SM
    Psychopharmacology (Berl); 1994 Dec; 116(4):433-6. PubMed ID: 7701045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls.
    Seifritz E; Gillin JC; Rapaport MH; Kelsoe JR; Bhatti T; Stahl SM
    Biol Psychiatry; 1998 Jul; 44(1):21-33. PubMed ID: 9646880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid tryptophan depletion plus a serotonin 1A agonist: competing effects on sleep in healthy men.
    Moore P; Seifritz E; Schlosser A; Greenfield D; Stahl S; Rapaport M; Kelsoe J
    Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S40-4. PubMed ID: 11682272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade.
    Seifritz E; Moore P; Trachsel L; Bhatti T; Stahl SM; Gillin JC
    Neurosci Lett; 1996 May; 209(1):41-4. PubMed ID: 8734905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
    Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
    Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone.
    Monti JM; Jantos H; Silveira R; Reyes-Parada M; Scorza C
    Pharmacol Biochem Behav; 1995 Oct; 52(2):305-12. PubMed ID: 8577795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):303-11. PubMed ID: 9303566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
    Cleare AJ; Forsling M; Bond AJ
    Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers.
    Staner L; Linker T; Toussaint M; Danjou P; Roegel JC; Luthringer R; Le Fur G; Macher JP
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):301-5. PubMed ID: 11532385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans.
    Wilson SJ; Bailey JE; Rich AS; Nash J; Adrover M; Tournoux A; Nutt DJ
    J Psychopharmacol; 2005 Nov; 19(6):609-13. PubMed ID: 16272182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: hypothermic, hormonal, and behavioral responses to ipsapirone.
    Shiah IS; Yatham LN; Lam RW; Zis AP
    Neuropsychopharmacology; 1997 Dec; 17(6):382-90. PubMed ID: 9397426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.
    Gelfin Y; Lerer B; Lesch KP; Gorfine M; Allolio B
    Psychopharmacology (Berl); 1995 Aug; 120(3):356-64. PubMed ID: 8524984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2003 Oct; 478(2-3):121-30. PubMed ID: 14575796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.
    Cohrs S; Meier A; Neumann AC; Jordan W; Rüther E; Rodenbeck A
    J Clin Psychiatry; 2005 Aug; 66(8):989-96. PubMed ID: 16086613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge.
    Lerer B; Gelfin Y; Gorfine M; Allolio B; Lesch KP; Newman ME
    Neuropsychopharmacology; 1999 Jun; 20(6):628-39. PubMed ID: 10327431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex.
    Wedzony K; Maćkowiak M; Fijał K; Gołembiowska K
    Eur J Pharmacol; 1996 Jun; 305(1-3):73-8. PubMed ID: 8813534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.